68 related articles for article (PubMed ID: 21804605)
21. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A
J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509
[TBL] [Abstract][Full Text] [Related]
22. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
Gual P; Le Marchand-Brustel Y; Tanti JF
Biochimie; 2005 Jan; 87(1):99-109. PubMed ID: 15733744
[TBL] [Abstract][Full Text] [Related]
23. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
Blanquart C; Boute N; Lacasa D; Issad T
Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
[TBL] [Abstract][Full Text] [Related]
24. Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.
Iijima Y; Okuda K; Tojo A; Tri NK; Setoyama M; Sakaki Y; Asano S; Tokunaga K; Kruh GD; Sato Y
Oncogene; 2002 Jun; 21(28):4374-83. PubMed ID: 12080468
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
[TBL] [Abstract][Full Text] [Related]
26. The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.
Esposito DL; Aru F; Lattanzio R; Morgano A; Abbondanza M; Malekzadeh R; Bishehsari F; Valanzano R; Russo A; Piantelli M; Moschetta A; Lotti LV; Mariani-Costantini R
PLoS One; 2012; 7(4):e36190. PubMed ID: 22558377
[TBL] [Abstract][Full Text] [Related]
27. IRS1 expression in hippocampus is age-dependent and is required for mature spine maintenance and neuritogenesis.
Sánchez-Sarasúa S; Meseguer-Beltrán M; García-Díaz C; Beltrán-Bretones MT; ElMlili N; Sánchez-Pérez AM
Mol Cell Neurosci; 2022 Jan; 118():103693. PubMed ID: 34942345
[TBL] [Abstract][Full Text] [Related]
28. IGF1 receptor expression protects against microenvironmental stress found in the solid tumor.
Peretz S; Kim C; Rockwell S; Baserga R; Glazer PM
Radiat Res; 2002 Aug; 158(2):174-80. PubMed ID: 12105987
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.
Gorgisen G; Hapil FZ; Yilmaz O; Cetin Z; Pehlivanoglu S; Ozbudak IH; Erdogan A; Ozes ON
Genet Mol Biol; 2019; 42(1):15-25. PubMed ID: 30807634
[TBL] [Abstract][Full Text] [Related]
30. IGF1R Deficiency Modulates Brain Signaling Pathways and Disturbs Mitochondria and Redox Homeostasis.
Cardoso S; López IP; Piñeiro-Hermida S; Pichel JG; Moreira PI
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33562061
[TBL] [Abstract][Full Text] [Related]
31.
Chi HT; Tram VN; Quan NT; Ly BTK
Biomed Rep; 2023 Jul; 19(1):47. PubMed ID: 37383677
[TBL] [Abstract][Full Text] [Related]
32. The IGF-I receptor and cancer.
Baserga R; Resnicoff M; Dews M
Endocrine; 1997 Aug; 7(1):99-102. PubMed ID: 9449042
[No Abstract] [Full Text] [Related]
33. Regression of
Alharbi M; Mobark NA; Balbaid AAO; Alanazi FA; Aljabarat WAR; Bakhsh EA; Ramkissoon SH; Abedalthagafi M
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923892
[No Abstract] [Full Text] [Related]
34. The experience of successful treatment of
Papusha L; Zaytseva M; Druy A; Valiakhmetova A; Yasko L; Salnikova E; Shekhtman A; Karachunsky A; Maschan A; Hwang EI; Novichkova G; Packer RJ
Neurooncol Adv; 2021; 3(1):vdab022. PubMed ID: 33738452
[No Abstract] [Full Text] [Related]
35. Correction to: The Medial Septum Is Insulin Resistant in the AD Presymptomatic Phase: Rescue by Nerve Growth Factor-Driven IRS
Sposato V; Canu N; Fico E; Fusco S; Bolasco G; Ciotti MT; Spinelli M; Mercanti D; Grassi C; Triaca V; Calissano P
Mol Neurobiol; 2019 Apr; 56(4):3068. PubMed ID: 30790233
[TBL] [Abstract][Full Text] [Related]
36. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL
Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
[TBL] [Abstract][Full Text] [Related]
37. The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations.
Kinnunen M; Liu X; Niemelä E; Öhman T; Gawriyski L; Salokas K; Keskitalo S; Varjosalo M
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686522
[TBL] [Abstract][Full Text] [Related]
38. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.
Hua J; Wang X; Ma L; Li J; Cao G; Zhang S; Lin W
Mol Cancer; 2022 Jun; 21(1):123. PubMed ID: 35668527
[TBL] [Abstract][Full Text] [Related]
39. Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes.
de la Fouchardière A; Tee MK; Peternel S; Valdebran M; Pissaloux D; Tirode F; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
Mod Pathol; 2021 Apr; 34(4):735-747. PubMed ID: 32968185
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
